Literature DB >> 8662786

Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells.

H J Kraft1, S Mosselman, H A Smits, P Hohenstein, E Piek, Q Chen, K Artzt, E J van Zoelen.   

Abstract

Expression of the platelet-derived growth factor alpha-receptor (PDGFalphaR) gene is tightly controlled in mammalian embryogenesis. A well established model system to study human embryogenesis is the embryonal carcinoma cell line Tera2. We have shown previously that retinoic acid-differentiated Tera2 cells express two PDGFalphaR transcripts of 6.4 kilobase pairs (kb) (encoding the full-length receptor) and 3.0 kb, respectively, whereas in contrast, undifferentiated Tera2 cells express PDFGalphaR transcripts of 1.5 kb and 5.0 kb. Here we show that this switch in PDGFalphaR expression pattern during differentiation of Tera2 cells results from alternative promoter use. In undifferentiated cells, a second promoter is used, which is located in intron 12 of the PDGFalphaR gene. Functional analysis shows that this promoter contains a consensus octamer motif, which can be bound by the POU domain transcription factor Oct-4. Oct-4 is expressed in undifferentiated Tera2 cells but not in retinoic acid-induced differentiated cells. Mutation of the octamer motif decreases promoter activity, while ectopic expression of Oct-4 in differentiated Tera2 cells specifically enhances the activity of this PDGFalphaR promoter. Therefore, we suggest that an important aspect in the maintenance of the undifferentiated state of human embryonal carcinoma cells results from Oct-4 expression, which thereupon activates this PDGFalphaR promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662786     DOI: 10.1074/jbc.271.22.12873

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.

Authors:  Xue-feng Fang; Wei-yi Zhang; Na Zhao; Wei Yu; Dong Ding; Xu Hong; Li-sha Li; Hua-rong Zhang; Shu Zheng; Biao-yang Lin
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

2.  Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.

Authors:  Song Liu
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

3.  Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer.

Authors:  Huan Zhou; Y U Hu; Weipeng Wang; Yong Mao; Jingjie Zhu; Bin Zhou; Jing Sun; Xueguang Zhang
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

4.  Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.

Authors:  Kang Wu; Haiyang Tang; Ruizhu Lin; Shane G Carr; Ziyi Wang; Aleksandra Babicheva; Ramon J Ayon; Pritesh P Jain; Mingmei Xiong; Marisela Rodriguez; Shamin Rahimi; Francesca Balistrieri; Shayan Rahimi; Daniela Valdez-Jasso; Tatum S Simonson; Ankit A Desai; Joe G N Garcia; John Y-J Shyy; Patricia A Thistlethwaite; Jian Wang; Ayako Makino; Jason X-J Yuan
Journal:  Pulm Circ       Date:  2020-09-10       Impact factor: 3.017

5.  The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2.

Authors:  M Nishimoto; A Fukushima; A Okuda; M Muramatsu
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

6.  Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.

Authors:  E Ben-Shushan; J R Thompson; L J Gudas; Y Bergman
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Altered regulation of platelet-derived growth factor receptor-alpha gene-transcription in vitro by spina bifida-associated mutant Pax1 proteins.

Authors:  P H Joosten; F A Hol; S E van Beersum; H Peters; B C Hamel; G B Afink; E J van Zoelen; E C Mariman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.

Authors:  Peixiang Wang; Donald R Branch; Meenakshi Bali; Gilbert A Schultz; Paul E Goss; Tianru Jin
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

9.  Tumor stem cells: A new approach for tumor therapy (Review).

Authors:  Min Meng; Xin-Han Zhao; Qian Ning; Lei Hou; Guo-Hong Xin; Li-Feng Liu
Journal:  Oncol Lett       Date:  2012-05-25       Impact factor: 2.967

10.  New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.

Authors:  V Botquin; H Hess; G Fuhrmann; C Anastassiadis; M K Gross; G Vriend; H R Schöler
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.